RYTHM, Inc. Reports Third Quarter 2026 Results

RYTHM, Inc. (RYM) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 RYTHM, Inc. Reports Third Quarter 2026 Results ROLLING MEADOWS, IL, November 4, 2026 – RYTHM, Inc. (Nasdaq: RYM) (“RYTHM” or the “Company”), America’s THC Company, whose portfolio of trusted THC brands includes RYTHM, Señorita, incredibles, Beboe, and Dogwalkers, tod

Event · Earnings
Also in this documentGuidance · withdraw

Facts are quoted from the filing text and checked against it.

Original reporting
Published Nov 4, 2026, 12:05 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 4, 2026, 12:06 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$RYM
Neutral
high confidence
Mentioned
$RYM
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$RYMNeutralMed
01

Why it matters

The Q3 earnings release provides the first public view of the company's latest performance and cash position, essential for valuation.

02

Market read

Earnings data may drive short‑term price movement; sector peers will watch regulatory developments.

03

What to watch

Potential impact of upcoming federal hemp‑derived THC rule changes could constrain future sales.

Relevance 7/10Novelty 7/10Timing: post‑market release

Background

RYTHM, Inc. (Nasdaq: RYM) is a publicly traded cannabis company focused on THC beverages and hemp‑derived products.

Company-level read

Ticker impact

$RYMNeutralHigh confidence
Context

SEC Form 8‑K discloses RYTHM's Q3 2026 results with revenue $23.9M, cash $48.2M and net loss $0.5M.

Expected impact

modest upside potential if investors view cash build and revenue growth positively, but no guidance may cap rally

Evidence & confidence

New quarterly numbers are primary disclosure; market will price revenue growth and cash position while awaiting Q4 outlook.

Market effects

THC beverage segment shows sequential growth, signaling expanding market for cannabis‑derived drinks.

Results reflect activity across 18 U.S. states, modestly influencing broader cannabis sector sentiment.

Limited to U.S. cannabis market; unlikely to affect global indices.

Counterpoint

Absence of Q4 guidance and regulatory headwinds may outweigh short‑term cash strength.

Key entities

  • RYTHM, Inc.

    US‑listed cannabis producer reporting Q3 2026 results.

  • Green Thumb Industries, Inc.

    Licensing partner mentioned in licensing amendment.

Related articles

$GTBIFMed

Green Thumb Amends RYTHM Notes and Warrants, Removes Ownership Cap; $72M Notes Affected

Green Thumb Industries (GTBIF) amended its secured convertible notes, pre-funded warrants, and shared services agreement with RYTHM to remove a 49.99% beneficial ownership cap. The amendment affects $72.0M of original principal and warrants for up to 9,731,638 shares, effective Oct 10, 2026. Green Thumb will consolidate RYTHM from that date, without intending to exercise the securities.

$RYMMed

RYTHM, Inc. Reports Second Quarter 2026 Results

RYTHM, Inc. (RYM) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 RYTHM, Inc. Reports Second Quarter 2026 Results ROLLING MEADOWS, IL, August 4, 2026 (GLOBE NEWSWIRE) – RYTHM, Inc. (Nasdaq: RYM) (“RYTHM” or the “Company”), America’s THC Company whose portfolio of trusted THC brands includes RYTHM, Señorita, incredibles, Beboe, and

$RYMMedAI 8/10

Daily NZX update, Friday, June 5, 2026

NZX 50 was up 0.3% at 3:00pm, though down 0.5% over five days and 2.6% over six months. Top gainers included Air New Zealand (+2%), Mainfreight (+2%) and Genesis Energy (+2%); biggest fallers were Kathmandu (-3%), A2 Milk (-2%) and Tourism Holdings (-2%). SmartShares ETFs were mixed. Meridian welcomed a draft Fast-track Panel decision on Lake Pūkaki access; Infratil completed a $200m capital bond offer; Ryman reported FY26 EBITDAF $88.3m and free cash flow $188.3m.

$RYMMedAI 8/10

Daily NZX update, Wednesday, June 3, 2026

NZX50 was down 0.3% at 3:00pm, though up 0.4% over five sessions and 6.5% over 12 months. Gentrack Group led gainers (+4%), while Vista Group fell the most (-3%). Ebos (-3%) and A2 Milk (-1%) also declined. Ryman Healthcare is considering new six-year secured bonds; Scales Corp declared a 12.5c FY2025 final dividend; Pacific Edge raised NZ$36.1m at NZ$0.17/share.